Risk factors
LENSAR (LNSR) risk factors
Item 1A of every LENSAR, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors80 risks8 new2 dropped18 reworded
Terminated merger with Alcon created substantial legal, financial, and retention risks for the company this year. Federal net operating losses increased to $52.6 million while regulatory disclosures shifted to smaller reporting company status. AI and medical device compliance frameworks expanded significantly.
Filed Mar 31, 2026 - FY2024 10-K risk factors74 risks
LENSAR faces continuing operating losses with a $143.3 million accumulated deficit as of December 31, 2024.
Filed Feb 27, 2025